Diakonos Oncology Revenue

Pharmaceutical Manufacturing • 1110 NASA Parkway, Houston, United States • 11-20 Employees

Diakonos Oncology revenue & valuation

Annual revenue	$1,539,990
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$5,000,000
Total funding	$31,400,000

Key Contacts at Diakonos Oncology

Donna Rill

Chief Technology Officer

Mike Wicks

Chief Executive Officer

Marcus Gohlke

Finance Director

Mike Wicks

Chief Executive Officer

Company overview

Headquarters	1110 NASA Parkway, Houston, TX 77058, US
Phone number	+104157127
Website	diakonosoncology.com
NAICS	3254
Founded	2016
Employees	11-20
Socials

Diakonos Oncology Email Formats

Diakonos Oncology uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@diakonosoncology.com), used 81.2% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@diakonosoncology.com	81.2%
{first initial}.{last name}	j.doe@diakonosoncology.com	18.8%

About Diakonos Oncology

Diakonos Oncology is pioneering cancer treatment with DOC1021, an FDA Fast Track-designated "double-loaded" dendritic cell therapy for glioblastoma (GBM) and pancreatic cancer (PDAC). This personalized, autologous therapy has shown exceptional safety and efficacy, achieving an 88% 12-month survival rate in unmethylated GBM Phase I trials, with 38% of patients still alive after 18–29 months. With a Phase II trial launching in Q1 2025 at top GBM centers nationwide, Diakonos is reshaping outcomes for patients with the most challenging cancers.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Manager

Employees by Department

Diakonos Oncology has 11 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Diakonos Oncology's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-09-26	3	$11,400,000
2025-06-30	4	$20,000,000

Funding Insights

$31,400,000

Total funding amount

$20,000,000

Most recent funding amount

Number of funding rounds

Diakonos Oncology Tech Stack

Discover the technologies and tools that power Diakonos Oncology's digital infrastructure, from frameworks to analytics platforms.

Cloudflare Bot Management

Security

Site Kit

Analytics

Swiper

JavaScript libraries

Microsoft 365

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

Locomotive Scroll

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Frequently asked questions

Diakonos Oncology is located in 1110 NASA Parkway, Houston, US.

You can reach Diakonos Oncology at +104157127.

Diakonos Oncology generates an estimated annual revenue of $1,539,990. This revenue figure reflects the company's market position and business performance in its industry.

Diakonos Oncology has an estimated valuation of $5,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Diakonos Oncology was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Diakonos Oncology has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Diakonos Oncology has raised a total of $31,400,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Diakonos Oncology

Donna Rill

Chief Technology Officer

Mike Wicks

Chief Executive Officer

Marcus Gohlke

Finance Director

Mike Wicks

Chief Executive Officer

4.8

40,000 users